AdvantaPure will exhibit its high purity tubing, manifolds, and disposable fluid processing systems at five pharmaceutical industry shows this spring. In addition to Interphex and the annual PDA Meeting, AdvantaPure will appear at Single Use Systems 2011 and two ISPE events. All five appearances give customers and prospects one-on-one contact with AdvantaPure's engineers.
Advanced Clinical's Executive Vice President Rosemarie Truman will speak on "How to Pick the Right Products/Solutions to Drive Profitable Growth" in biotechnology at the BioFlorida Event in Miami.
The 2011 Advanced Quality and Regulatory Symposium for the Biotech and Medical Devices Industry Conference will address the latest regulatory requirements for the development of clinical trials, regulatory submission, and quality systems regulatory requirements for devices, drugs and biologics products.
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Gilenyaź (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosis (MS) despite treatment with beta interferon, or in patients with rapidly evolving severe relapsing-remitting MS.
As part of the preparation for the Global Companion Diagnostics Forum IQPC have put together a short survey on Companion Diagnostics issues. The survey takes only a couple of minutes to complete and can be accessed here: http://www.surveymonkey.com/s/CDX
The first-in-class topical Minocycline product, protected by 4 patent applications, is directed for the treatment of Rosacea, Acne, Skin Infections and Chronic Wounds.
As Turkey, France and California become the first to move to 2D data matrix barcodes on pharmaceutical packaging, Fairfield launch a cost effective scan solution; the only system on the market that can read all three utilised barcodes in one simple scan.
MarketHATCH Patient Acquisition Programs benefit patients, providers,pharmacists and manufacturers. Our coupon and rebate programs are cost effective, easily implemented and impacted. We always have our focus on agreat patient experience.
Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
Pharmaceutical market in the Asia Pacific region is anticipated to grow at a CAGR of nearly 12% during 2011-2013, says a new research report from RNCOS.
Novartis has received approval from Japan's Ministry of Health, Labour and Welfare to offer Tasignaź (nilotinib) as a treatment for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Pharma IQ has conducted an interview with Chrissie Fletcher, Director and Head of International Biostatistics at Amgen, about Health Technology Assessment.
The Anti-Counterfeiting Trade Agreement (ACTA), a proposed agreement created for the purpose of establishing international standards regarding the enforcement of intellectual property rights, sparked many controversies about the parts relating to the online counterfeiting.
Dr Karl Broich, Vice President, BfArM, will discuss the new regulatory landscape as well as projected amendments to the current guidance documents on CNS clinical trials at Optimising Clinical Development for CNS conference, 15-16 February 2011 in London.
IV Ukrainian practical conference on logistics named "Logistics: Strategic cooperation" took place on 26th of November in Kiev. More than 150 professionals and experts of various logistics branches visited this event.
Partnerships are now available for new topical antibiotic that kills all Gram-positive and Gram-negative bacteria pathogens that have been available for testing.
On December 9 Daya Medicals, Inc. will present its the new dynamic product, the MedPod, to a select group of industry specialists and health care professionals. This will be the first public viewing and demonstration of the product.
Advanced Clinical announces that Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.
CMDBioscience, a CT based biotechnology company specializing in computer-aided peptide drug discovery, announced today the completion of a research collaboration aimed at identifying novel peptide antagonists of the dengue virus using the CMDBioscience proprietary computational peptide drug discovery platform.
Crystal Pharmatech focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations. Its core services include: salt/polymorph screening, cocrystal screening, chiral resolution, and solid state NMR.
The French Trade Commission UBIFRANCE in London will showcase five innovative companies from the biotechnology and pharmaceutical sectors at the Genesis Conference, which will be held on 9 December 2010 at the Queen Elizabeth II Conference Centre in central London. These French companies are aiming to establish new professional contacts and explore business opportunities between France and the UK.
IN CELL ART, a biotechnology company involved in macromolecular drug (siRNA or DNA) delivery systems, has announced today that the company has entered into a research collaboration agreement with Merial to evaluate IN CELL ART'S nanocarrier technologies in the context of Merial's vaccines programme.
Satisfied Users & 
Approved Press Releases
